These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39463366)

  • 21. Ophthalmic immunoglobulin G4-related disease IgG4-RD Current concepts.
    Mulay K; Wick MR
    Semin Diagn Pathol; 2016 May; 33(3):148-55. PubMed ID: 26897039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG4-Related Diseases in the Gastrointestinal Tract: Clinical Presentation, Diagnosis and Treatment Challenges.
    Backhus J; Seufferlein T; Perkhofer L; Hermann PC; Kleger A
    Digestion; 2019; 100(1):1-14. PubMed ID: 30384361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Advances in the Study of IgG4-Related Disease in the Eye and Ocular Adnexa.
    Zhang X; Wu G; Wang M; Tian Y; Chen F; Chen B; Wu H
    Ophthalmic Res; 2022; 65(6):605-614. PubMed ID: 35843209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin G4-related disease: case report and literature review.
    Dong LL; Sheikh IS; Huang AH; Wu XH; Chen EG; Ying KJ
    Immunol Res; 2021 Oct; 69(5):415-421. PubMed ID: 34374950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The different forms of IgG4-related disease].
    Roeloffs MWK; Hubers LM; Oomens MAEM; Beuers U
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30212027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
    Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
    Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease.
    Kubota T; Katayama M; Nishimura R; Moritani S
    Br J Ophthalmol; 2020 Mar; 104(3):345-349. PubMed ID: 31272957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging therapy options for IgG4-related disease.
    Lanzillotta M; Fernàndez-Codina A; Culver E; Ebbo M; Martinez-Valle F; Schleinitz N; Della-Torre E
    Expert Rev Clin Immunol; 2021 May; 17(5):471-483. PubMed ID: 33689549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease.
    Wang R; He D; Zhao L; Liang S; Liang D; Xu F; Zhang M; Zhu X; Chen H; Xie H; Zeng C; Tang Z; Liu Z
    Hum Pathol; 2018 Nov; 81():220-228. PubMed ID: 30031099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and pathological study on IgG4-related ophthalmic disease involving the lacrimal gland].
    Li HQ; Lin JY; Zhao H
    Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):834-841. PubMed ID: 31715680
    [No Abstract]   [Full Text] [Related]  

  • 31. IgG4-related ophthalmic disease masquerading as ciliary body tumors and scleritis in both eyes: a case report.
    Ma J; Xie M; Long K; Deng M; Zhou L; Luo J
    BMC Ophthalmol; 2023 Mar; 23(1):92. PubMed ID: 36894878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an algorithm for IgG4-related disease management.
    Orozco-Gálvez O; Fernández-Codina A; Lanzillotta M; Ebbo M; Schleinitz N; Culver EL; Rebours V; D'Cruz DP; Della-Torre E; Martínez-Valle F
    Autoimmun Rev; 2023 Mar; 22(3):103273. PubMed ID: 36682575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.
    McNab AA; McKelvie P
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):167-78. PubMed ID: 25564258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study.
    Liu X; Shao C; Yu C; Huang H; Pan R; Xu K; Zhang X; Xu Z
    BMC Pulm Med; 2022 Apr; 22(1):141. PubMed ID: 35413899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents.
    Hong X; Zhang YY; Li W; Liu YY; Wang Z; Chen Y; Gao Y; Sun ZP; Peng X; Su JZ; Cai ZG; Zhang L; He J; Ren LM; Yang HY; Li ZG; Yu GY
    Arthritis Res Ther; 2018 Jan; 20(1):12. PubMed ID: 29382364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG4-related disease in a patient with HIV infection.
    Ron R; Ruz-Caracuel I; García E; Montes-Ramírez ML
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30988103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG4-Related Ophthalmic Disease.
    Huang YM; Lin PH
    N Engl J Med; 2022 Jun; 386(24):2315. PubMed ID: 35704484
    [No Abstract]   [Full Text] [Related]  

  • 38. Ocular adnexal marginal zone lymphoma arising in a patient with IgG4-related ophthalmic disease.
    Nishida K; Sogabe Y; Makihara A; Senoo A; Morimoto H; Takeuchi M; Gion Y; Yoshino T; Sato Y
    Mod Rheumatol; 2019 Mar; 29(2):383-387. PubMed ID: 27686866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG4-related uveitis. A French cohort and literature review.
    Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
    Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IgG4-negative IgG4-related disease with a cardiac mass: A case report.
    Namba K; Sakai D; Mikamo H; Sugizaki Y; Sugiura Y; Hiruta N; Matsuzawa Y; Kaneko K
    Medicine (Baltimore); 2023 Aug; 102(31):e34533. PubMed ID: 37543826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.